Loading
Latest filing published 24 Sept 2026 for CLARITY PHARMACEUTICALS LTD. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of 2. Changes in relevant interests across 2 companies, led by Clarity Pharmaceuticals Ltd and CU6. The record holds 6 filings, for trades running from 18 June 2026 to 22 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 24 September 2026 came the latest disclosure, a transaction in Clarity Pharmaceuticals Ltd. The median gap between a trade and its publication by ASX is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations